Search

everythinglearnresearchcommunity

for

Search:↓

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Doctors need to be better prepared to assess and treat obesity in patients.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Lamins are vital for cell survival, organ development, and preventing premature aging.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.